Naoxueshu Oral Liquid Accelerates Post-Craniotomy Hematoma Absorption in Patients: An Open-Label, Multicenter, and Randomized Controlled Trial.

OBJECTIVE: To investigate whether Naoxueshu Oral Liquid (NXS) could promote hematoma absorption in post-craniotomy hematoma (PCH) patients. METHODS: This is an open-label, multicenter, and randomized controlled trial conducted at 9 hospitals in China. Patients aged 18-80 years with post-craniotomy supratentorial hematoma volume ranging from 10 to 30 mL or post-craniotomy infratentorial hematoma volume less than 10 mL, or intraventricular hemorrhage following cranial surgery were enrolled. They were randomly assigned at a 1:1 ratio to the NXS (10 mL thrice daily for 15 days) or control groups using a randomization code table. Standard medical care was administered in both groups. The primary outcome was the percentage reduction in hematoma volume from day 1 to day 15. The secondary outcomes included the percentage reduction in hematoma volume from day 1 to day 7, the absolute reduction in hematoma volume from day 1 to day 7 and 15, and the change in neurological function from day 1 to day 7 and 15. The safety was closely monitored throughout the study. Moreover, subgroup analysis was performed based on age, gender, history of diabetes, and etiology of intracerebral hemorrhage (ICH). RESULTS: A total of 120 patients were enrolled and randomly assigned between March 30, 2018 and April 15, 2020. One patient was lost to follow-up in the control group. Finally, there were 119 patients (60 in the NXS group and 59 in the control group) included in the analysis. In the full analysis set (FAS) analysis, the NXS group had a greater percentage reduction in hematoma volume from day 1 to day 15 than the control group [median (Q1, Q3): 85% (71%, 97%) vs. 76% (53%, 93%), P<0.05]. The secondary outcomes showed no statistical significance between two groups, either in FAS or per-protocol set (P>0.05). Furthermore, no adverse events were reported during the study. In the FAS analysis, the NXS group exhibited a higher percentage reduction in hematoma volume on day 15 in the following subgroups: male patients, patients younger than 65 years, patients without diabetes, or those with initial cranial surgery due to ICH (all P<0.05). CONCLUSIONS: The administration of NXS demonstrated the potential to promote the percentage reduction in hematoma volume from day 1 to day 15. This intervention was found to be safe and feasible. The response to NXS may be influenced by patient characteristics. (Registration No. ChiCTR1800017981).

A Localized High-Concentration Water/Organic Hybrid Electrolyte for 2.5 V Li4Ti5O12/LiMn2O4 Batteries.

The "solvent-in-salt" electrolytes for an aqueous system, including "water-in-salt" electrolytes and "bisolvent-in-salt" electrolytes, have shown significantly improved electrochemical stability toward low-voltage anodes and high-voltage cathodes. However, the heavy use of salt raises concerns of high cost, high viscosity, inferior wettability, and poor low-temperature performance. Herein, a "localized bisolvent-in-salt electrolyte" is proposed by introducing 1,1,2,2-tetrafluoroethyl-2,2,3,3-tetrafluoropropyl ether (TTE) as the diluent to the high-concentration water/sulfolane hybrid (BSiS-SL) electrolytes, forming a ternary solvent-based electrolyte, Li(H2O)0.9SL1.3·TTE1.3 (HS-TTE). The introduction of TTE dilutes the compact ionic clusters, while the original primary Li+ solvation structure remains, and in the meantime, boosts the formation of a robust solid electrolyte interphase. As a result, a wide electrochemically stable window of 4.4 V is achieved. In comparison with the bisolvent BSiS-SL system, the trisolvent HS-TTE electrolyte exhibits a low salt concentration of 2.1 mol kg-1, resulting in drastically reduced viscosity, superb separator wettability, and largely improved low-temperature performance. The constructed 2.5 V Li4Ti5O12/LiMn2O4 cell shows an excellent capacity retention of 80.7% after 800 cycles, and the cell can even work at -30 °C. With these extraordinary advantages, the fundamental designing strategy of the HS-TTE electrolyte developed in this work can promote the practical applications of solvent-in-salt electrolytes.

Tuning the Electrolyte Solvation Structure via a Nonaqueous Co-Solvent to Enable High-Voltage Aqueous Lithium-Ion Batteries.

"Water-in-salt" electrolytes have significantly expanded the electrochemical stability window of the aqueous electrolytes from 1.23 to 3 V, making highly safe 3.0 V aqueous Li-ion batteries possible. However, the awkward cathodic limit located at 1.9 V (versus Li+/Li) and the high cost of the expensive salts hinder the practical applications. In this work, an ideal "bisolvent-in-salt" electrolyte is reported to tune the electrolyte solvation structure via introducing sulfolane as the co-solvent, which significantly enhances the cathodic limit of water to 1.0 V (versus Li+/Li) at a significantly reduced salt concentration of 5.7 mol kg-1. Due to the competitive coordination of sulfolane, water molecules that should be in the primary solvation sheath of Li+ are partly substituted by the electrochemically stable sulfolane, significantly decreasing the hydrogen evolution. Meanwhile, the unique electrolyte structures enable the formation and stabilization of a robust solid electrolyte interphase. As a result, a 2.4 V LiMn2O4/Li4Ti5O12 full cell with a high energy density of 128 Wh kg-1 is realized. The hybrid water/sulfolane electrolytes provide a brand new strategy for designing aqueous electrolytes with an expanded electrochemical stability window at a low salt concentration.

Solid/Quasi-Solid Phase Conversion of Sulfur in Lithium-Sulfur Battery.

The lithium-sulfur (Li-S) battery is considered as one of the most promising options because the redox couple has almost the highest theoretical specific energy (2600 Wh kg-1 ) among all solid anode-cathode candidates for rechargeable batteries. The "solid-liquid-solid" mechanism has become a dominating phase transformation process since it was first reported, although this cathode mode suffers from a tough "shuttle" phenomenon due to the dissolution of the soluble intermediate polysulfides generated during the charging-discharging process, which causes rapid loss of energy-bearing material and shortened lifespan. For decades, tremendous efforts have been made to restrict the shuttle effect. Changing sulfur conversion to "solid-solid" mode or "quasi-solid" mode, which successfully exceed the limit of the dissolution of the intermediates, and may address the root of the problem. In this review, the main focus is on the fundamental chemistry of the "solid-solid" and "quasi-solid" phase transformation of the sulfur cathode. First, the strategies of sulfur immobilization in "solid-liquid-solid" multi-phase conversions as well as the pivotal influence factors for the electrochemical conversion process are briefly introduced. Then, the different routes are summarized to realize the "solid-solid" and "quasi-solid" redox mechanisms. Finally, a perspectives on building high-energy-density Li-S batteries are provided.

Stable Room-Temperature Sodium-Sulfur Batteries in Ether-Based Electrolytes Enabled by the Fluoroethylene Carbonate Additive.

Because of its high energy density and low cost, the room-temperature sodium-sulfur (RT Na-S) battery is a promising candidate to power the next-generation large-scale energy storage system. However, its practical utilization is hampered by the short life span owing to the severe shuttle effect, which originates from the "solid-liquid-solid" reaction mechanism of the sulfur cathode. In this work, fluoroethylene carbonate is proposed as an additive, and tetraethylene glycol dimethyl ether is used as the base solvent. For the sulfurized polyacrylonitrile cathode, a robust F-containing cathode-electrolyte interphase (CEI) forms on the cathode surface during the initial discharging. The CEI prohibits the dissolution and diffusion of the soluble intermediate products, realizing a "solid-solid" reaction process. The RT Na-S cell exhibits a stable cycling performance: a capacity of 587 mA h g-1 is retained after 200 cycles at 0.2 A g-1 with nearly 100% Coulombic efficiency.

Improving Na/Na3 Zr2 Si2 PO12 Interface via SnOx /Sn Film for High-Performance Solid-State Sodium Metal Batteries.

Sodium (Na) metal batteries have attracted much attention due to their rich resources, low cost, and high energy density. As a promising solid electrolyte, Na3 Zr2 Si2 PO12 (NZSP) is expected to be used in solid-state Na metal batteries addressing the safety concerns. However, due to the poor contact between NZSP and the Na metal, the interfacial resistance is too large to gain proper performance for practical solid-state batteries (SSBs) application. Here, a SnOx /Sn film is successfully introduced to improve the interface between Na and NZSP for enhancing the electrochemical performance of SSBs. As a result, the Na/NZSP interfacial resistance is dramatically reduced from 581 to 3 Ω cm2 . The modified Na||Na symmetric cell keeps cycling over 1500 h with an overpotential of 40 mV at 0.1 mA cm-2 at room temperature. Even at current densities of 0.3 and 0.5 mA cm-2 , the cell still maintains an excellent cyclability. When coupled with NaTi2 (PO4 )3 and a Na3 V2 (PO4 )3 cathode, the full-cell demonstrates a good performance at 0.2 C and 1 C, respectively. The present work provides an effective way to solve the interface issue of SSBs.

Paper-Based Constant Potential Electrochemiluminescence Sensing Platform with Black Phosphorus as a Luminophore Enabled by a Perovskite Solar Cell.

Exploring efficient luminophores in the electrochemiluminescence (ECL) system is highly desired to pursue a sensitive ECL sensing platform. Herein, the black phosphorus nanosheets (BP NSs) with excellent ECL properties are investigated and serve as the luminophore with the coreactant of peroxydisulfate (S2O82-) solution. Moreover, owing to the overlapping of emission and absorbance spectra, effective resonance energy transfer (RET) is realized between the BP NSs and the introduced Au nanoparticles. In order to achieve the portable and miniaturized developing trends for the paper-based ECL sensing platform, a paper-based perovskite solar cell (PSC) device is designed to act as the power source to replace the commonly utilized expensive and cumbersome electrochemical workstation. Benefiting from that, a PSC driven paper-based constant potential ECL-RET sensing platform is constructed, thereby realizing sensitive microRNAs (miRNAs) detection. What's more, to attain the preferable analytical performance, the duplex-specific nuclease (DSN) is also introduced to assist the target recycling signal amplification strategy. Based on this, highly sensitive detection of miRNA-107 with a range from 0.1 pM to 15 nM is achieved by this designed sensing platform. Most importantly, this work not only pioneers a precedent for developing a high-sensitivity PSC triggered ECL sensing platform but also explores the application prospect of BP nanomaterial in the field of bioanalysis.

Polymer Complex Fiber for Linear Actuation with High Working Density and Stable Catch-State.

Fiber-based linear actuators (FLAs) are a key module in microrobots and biomimetic devices. It has been a great challenge to develop linear actuators that can balance output stress and output strain and hence provide high working density. Herein, we report the preparation and performance of a FLA system made from commercially available materials and allowed mass production at relatively low cost. The FLAs can lift up or lay down objects more than 1000 times of its own weight during active contraction and expansion under environmental stimuli. The contraction ratio and output stress can reach 30% and 0.24 MPa, respectively, and the sustainable work density is about 80 J/kg, which is 10 times the typical value of human skeletal muscles. Especially, the FLAs show stable catch-state (lock-up state) with no creeping and no further energy consumption.

Ganoderma lucidum Exerts an Anticancer Effect on Human Osteosarcoma Cells via Suppressing the Wnt/ß-Catenin Signaling Pathway.

Background: Current treatment of osteosarcoma is limited in part by side effects and low tolerability, problems generally avoided with traditional Chinese medicine. Ganoderma lucidum, a traditional Chinese medicine with antitumor effects, offers a potential alternative, but little is known about its molecular mechanisms in osteosarcoma cells. Objective: To investigate the effect of G lucidum on osteosarcoma cells and its mechanism. Methods: Osteosarcoma MG63 and U2-OS cells were treated with G lucidum, followed by assays for cell proliferation (Cell Counting Kit-8), colony formation, and apoptosis (Alexa Fluor 647-Annexin V/propidium iodide, flow cytometry). Migration and invasion of cells were assessed by wound healing and Transwell invasion assays, and the effect of G lucidum on Wnt/ß-catenin signal transduction was studied by real-time quantitative polymerase chain reaction, western blot, and dual-luciferase assay. Results:G lucidum inhibited the proliferation, migration, and invasion, and induced apoptosis of human osteosarcoma MG63 and U2-OS cells. Dual-luciferase assay showed that G lucidum suppressed the transcriptional activity of T-cell factor/lymphocyte enhancer factor in the Wnt/ß-catenin signaling pathway. Moreover, G lucidum blocked Wnt/ß-catenin signaling by inhibiting the Wnt co-receptor LRP5 and Wnt-related target genes, such as ß-catenin, cyclin D1, C-Myc, MMP-2, and MMP-9. At the same time, when Wnt/ß-catenin was inhibited, the expression of E-cadherin was upregulated. Conclusions: Our results suggest that G lucidum broadly suppresses osteosarcoma cell growth by inhibiting Wnt/ß-catenin signaling.

Recent Advances in Cathode Materials for Room-Temperature Sodium-Sulfur Batteries.

Room-temperature sodium-sulfur (RT-Na/S) batteries hold great promise to meet the requirements of large-scale energy storage due to their high theoretical energy density, low material cost, resource abundance, and environmental benignity. However, the poor cycle performance and low utilization of active sulfur greatly hinder their practical application. As the essential part directly related to the battery performance, the S-based cathode has attracted tremendous research interests in recent years. This review highlights recent progress in cathode materials for RT-Na/S batteries. Particularly, basic insights into the Na/S reaction mechanism are presented and representative works on S-based cathode materials are systematically summarized. The remaining challenges and developing trends of RT-Na/S batteries are also discussed. We hope this review can shed light on the field of next-generation metal-sulfur batteries.

Inhibition of BECN1 Suppresses Lipid Peroxidation by Increasing System Xc- Activity in Early Brain Injury after Subarachnoid Hemorrhage.

Lipid peroxidation plays a crucial role in early brain injury (EBI) after subarachnoid hemorrhage (SAH), and cystine/glutamate antiporter system Xc- has been proved to be associated with glutathione (GSH) synthesis, which protects cells against oxidative damage. Antioxidant effect of system Xc- is mediated by Beclin 1 (BECN1). Therefore, this study aimed to determine whether administration of BECN1 small interfering RNA (siRNA) could attenuate EBI after SAH experiment, specifically through suppressing lipid peroxidation and increasing system Xc- activity. Endovascular perforation was performed to induce SAH in a rat model and BECN1 siRNA was administered through intracerebroventricular injection. Neurological score, brain edema, lipid peroxidation (malondialdehyde, MDA), and antioxidation system, containing GSH, glutathione peroxidase (GSH-Px), glutathione reductase (GR), and anti-reactive oxygen species (anti-ROS), were examined. The expression of BECN1 and light chain of system Xc- (xCT) was detected by western blot, immunoprecipitation, and immunofluorescence staining. This study confirmed that SAH induced neurological deficits and brain edema, which was accompanied by the increase of BECN1 expression and lipid peroxidation, and the decrease of xCT expression and antioxidative capacity. However, downregulation of BECN1 by siRNA could decrease the formation of the BECN1-xCT complex and lipid peroxidation, enhance antioxidative capacity, and ameliorate neurological deficits and brain edema in SAH rats. The results suggested that inhibition of BECN1 suppresses accumulation of lipid peroxidation by increasing system Xc- activity in EBI after SAH, and BECN1 may be a new effective target for EBI treatment after SAH.

Stenosing tenosynovitis : Evaluation of percutaneous release with a specially designed needle vs. open surgery.

PURPOSE: The purpose of this study was to evaluate the effectiveness of conventional open surgery and percutaneous release with a specially designed needle for treating stenosing tenosynovitis in terms of cure, relapse and complication rates. METHODS: In this study 89 fingers from 76 patients were randomly assigned and allocated to one of the treatment groups. A total of 37 patients were treated with open surgery in group 1 and 39 patients with percutaneous release using a specially designed needle in group 2. A patient-based 4-inch visual analogue scale (VAS), Quinnell grading (QG), disability of arm shoulder and hand (DASH) score and finger total joint range of motion (FTROM) score were evaluated before treatment and after 7, 30 and 180 days. When finger QG scores were equal or greater than 2 points at follow-up at 180 days this was defined as recurrence.. RESULTS: There were no significant differences between the two groups (P > 0.05) in terms of VAS, DASH and QG scores and the degree of FTROM. At 7 days all the data were significantly different (p < 0.05) compared with preoperative data, 30 days was significantly different (p < 0.05) compared with 7 days while at 180 days no significant differences could be found (p > 0.05) compared with 30 days. The recurrence rate in group 1 was 4.65% and 6.55% in group 2. CONCLUSION: The percutaneous release and open surgery methods displayed similar effectiveness regarding the cure and recurrence of trigger finger disorder. The use of a specially designed needle for release is a safe and reliable method.

Reliability, Validity, and Responsiveness of the Chinese Version of the Knee Injury and Osteoarthritis Outcome Score (KOOS) in Patients with Anterior Cruciate Ligament Reconstruction in Mainland China.

OBJECTIVE: The aim of this study was to perform a cross-cultural adaption of the KOOS into Chinese and to evaluate its psychometric properties in patients with anterior cruciate ligament reconstruction (ACL reconstruction) in mainland China. DESIGN: A cross-sectional study. SETTING: Patients completed the Chinese version of the KOOS and the SF-36 questionnaire three times. We evaluated the reliability, checked the validity, and assessed the responsiveness. PARTICIPANTS: A total of 42 patients who had undergone ACL reconstruction. MAIN OUTCOME MEASURES: The results of the questionnaire survey. RESULTS: The Chinese version of the KOOS was well accepted, with ideal test-retest reliability and internal consistency. The test-retest reliability was significant, with high ICC values ranging from 0.888 to 0.941. Additionally, we found that the internal consistency was adequate, with Cronbach's alpha coefficient ranging from 0.740 to 0.975. All a priori hypotheses were supported by a high correlation between the KOOS and SF-36. Furthermore, responsiveness was demonstrated since the ES and SRM between subscales following ACL reconstruction was found in the expected pattern. CONCLUSIONS: The Chinese version of the KOOS showed psychometric properties demonstrating acceptable reliability and validity similar to the original version. We conclude that the Chinese version is a reliable and valid instrument for research and clinical assessments of ACL reconstruction patients in mainland China.

Trends and patterns of incidence of diffuse glioma in adults in the United States, 1973-2014.

INTRODUCTION: The objective of the study was to identify trends in incidence of adult diffuse gliomas in the United States and evaluate the contribution of age, period, and cohort effects to the trends. METHODS: Using the Surveillance, Epidemiology, and End Results 9 database, primary diffuse glioma patients (≥20 years old) diagnosed from 1973 to 2014 were identified. Incidence trends were analyzed using joinpoint regression and age-period-cohort modeling. RESULTS: Overall, the incidence for adult glioma decreased slowly from 1985 to 2014 (annual percent change [APC] = 0.5%, 95% confidence intervals [CI], 0.3%-0.6%). In histology subtype-stratified analysis, glioblastoma and nonglioblastoma exhibited opposite trends. The incidence for glioblastoma increased from 1978 to 2014 (APC for year 1978-1992 = 2.7%, 95% CI, 1.8%-3.6%; APC for 1992-2014 = 0.3%, 95% CI, 0%-0.6%), while the incidence for nonglioblastoma decreased significantly from 1982 to 2014 (APC = 2.2%, 95% CI, 2.0%-2.5%). Age-period-cohort modeling revealed significant period and cohort effects, with the patterns for glioblastoma and nonglioblastoma distinctive from each other. Compared with adults born 1890s, those born 1920s had approximately 4-fold the risk of glioblastoma after adjustment of age and period effects, while the risk of nonglioblastoma was reduced by half in individuals in the 1939 cohort as compared with those in the 1909 cohort. CONCLUSIONS: The results support the hypothesis of etiological heterogeneity of diffuse gliomas by histology subtypes. The established risk factors cannot fully explain the distinct patterns by histology subtypes, which necessitate further epidemiological studies.

Connexin 43 Modulates Osteogenic Differentiation of Bone Marrow Stromal Cells Through GSK-3beta/Beta-Catenin Signaling Pathways.

BACKGROUND/AIMS: Bone marrow stromal cells (BMSCs) are multipotent precursors that give rise to osteoblasts, and contribute directly to bone formation. Connexin 43 (Cx43) is the most ubiquitous gap junction protein expressed in bone cell types, and plays crucial roles in regulating intercellular signal transmission for bone development, differentiation and pathology. However, the precise role and mechanism of Cx43 in BMSCs are less known. Here, we investigate the function of Cx43 in osteogenic differentiation of BMSCs in vitro. METHODS: BMSCs were isolated by whole bone marrow adherent culture. Knock down of Cx43 was performed by using lentiviral transduction of Cx43 shRNA. BMSCs were induced to differentiate by culturing in a-MEM, 10% FBS, 50 µM ascorbic acid, 10 mM beta-glycerophosphate, and 100 nM dexamethasone. Alkaline phosphatase (ALP) activity and alizarin red S staining were used to evaluate osteogenic differentiation in calcium nodules. Target mRNAs and proteins were analyzed by using real-time quantitative PCR (qPCR) and western blotting. RESULTS: Cx43 expression markedly increased during osteogenic differentiation. Osteogenic differentiation was suppressed following lentiviral-mediated knockdown of Cx43 expression, as judged by decreased levels of Runt-related transcription factor 2 (Runx2), bone sialoprotein (BSP), osteocalcin (Bglap), Osterix (Osx), alkaline phosphatase (ALP) activity and the number of calcium nodules in response to osteogenic differentiation stimuli. Knock down of Cx43 reduced the level of phosphorylation of GSK-3beta at Ser9 (p-GSK-3beta), resulting in decreased beta-catenin expression and activation. Furthermore, treatment of Cx43-knockdown cells with lithium chloride (LiCl), a GSK-3beta inhibitor, reduced osteogenic differentiation and decreased GSK-3beta levels, as well as partially rescued levels of both total and activated beta-catenin. CONCLUSION: These findings indicate that Cx43 positively modulates osteogenic differentiation of BMSCs by up-regulating GSK-3beta/beta-catenin signaling pathways, suggesting a potential role for Cx43 in determining bone mass and bone mineral density by modulating osteogenesis.

pH-Responsive Janus Film Constructed with Hydrogen-Bonding Assembly and Dopamine Chemistry.

Poly(acrylic acid) (PAA) was partially grafted with dopamine (PAA-dopa), and then layer-by-layer assembled with poly(vinylpyrrolidone) (PVPON) to prepare hydrogen-bonded (PVPON/PAA-dopa) n film. Polydopamine (PDA) was deposited on (PVPON/PAA-dopa) n film in the presence of oxidant, and hence the whole (PVPON/PAA-dopa) nPDA film was cross-linked. (PVPON/PAA-dopa) nPDA could be utilized as a platform to produce the free-standing Janus film because of the easy detaching process and various chemical reactivity of PDA layer. Ag nanoparticles were formed on (PVPON/PAA-dopa) nPDA film by electroless metallization. 1 H,1 H,2 H,2 H-Perfluorodecanethiol (PFDT) was used to further modify the film through Michael addition. After detaching from the substrate, (PVPON/PAA-dopa)20PDA/Ag/PFDT exhibits reversible swelling-shrinking behavior as the pH value changes. This free-standing film shows Janus character, one side is hydrophobic, whereas the other side is hydrophilic. In addition, the hydrophobic surface exhibits a surface-enhanced Raman scattering effect, whereas the hydrophilic side does not.

Dual-phase Cone-beam CT-based Navigation Imaging Significantly Enhances Tumor Detectability and Aids Superselective Transarterial Chemoembolization of Liver Cancer.

RATIONALE AND OBJECTIVES: The objective of this study was to investigate the impact of a dual-phase cone-beam computed tomography (DP-CBCT)-based navigation imaging during transarterial chemoembolization (TACE) of hepatocellular carcinoma (HCC) in a perspective randomized study. MATERIALS AND METHODS: Forty-two patients with HCC (39 men, 57 ± 9 years, 13 first-time TACE) underwent TACE using three-dimensional image guidance with automatic detection of tumor-feeding vessels computed from DP-CBCT (early and delayed arterial phases). Forty-nine other patients with HCC (44 men, 55 ± 12 years, 14 first-time TACE) were treated conventionally using digital subtraction angiography (DSA). Tumor detectability in DP-CBCT was compared to DSA and preoperative CT or magnetic resonance (MR) imaging. Tumor-feeding vessel visibility was rated (good, fair, and poor) intraoperatively by the operators. The superselective embolization success rate, the number of DSA acquisitions, fluoroscopy time, and patient radiation dose were collected and compared using paired t test and the Mann-Whitney U test. RESULTS: Tumor detection of DP-CBCT was superior to DSA (100% vs 83%, P = .001) and comparable to CT-MR (96%, P = .456). Tumor and feeder visibilities were significantly enhanced by DP-CBCT (P < .001). Compared to using DSA, more superselective embolization was achieved (60% vs 49%) with less DSA acquisitions (n = 2.6 ± 0.8 vs n = 3.4 ± 0.7, P < .001) and shorter fluoroscopy time (4.1 ± 2.6 vs 7.1 ± 4.2 minutes, P < .001) with a slight increase in patient radiation exposure, that is, air kerma (median: 0.33, first to third quartiles: 0.24-0.48 vs 0.30, 0.24-0.44 Gy; P = .519) and dose-area product (134, 92-181 vs 97, 75-140 Gy⋅cm2, P = .048). CONCLUSIONS: DP-CBCT and navigation imaging improve tumor detectability and superselective embolization in TACE.

RACK1 Silencing Induces Cell Apoptosis and Inhibits Cell Proliferation in Hepatocellular Carcinoma MHCC97-H Cells.

This study aimed to explore the effects of RACK1 gene silencing on the apoptosis and proliferation of hepatocellular carcinoma (HCC) MHCC97-H cells. After transfecting MHCC97-H cells with siRNA, RACK1 gene silencing model was established. The cells were divided into blank group, siRNA group and empty plasmid group, respectively. The mRNA and protein expressions of RACK1, cyclin D1 and BAX were determined by qRT-PCR and Western blotting. CCK-8 assay, flow cytometry and FITC-Annexin V/PI staining were used to determine cell viability, cell cycle and cell apoptosis, respectively. The results of qRT-PCR and Western blotting suggested that when compared with the blank group and the empty plasmid group, the mRNA and protein expressions of RACK1 and Cyclin D1 decreased significantly while the mRNA and protein BAX expressions increased substantially in the siRNA group (all P < 0.05). The results of CCK-8 assay revealed that the siRNA group exhibited significantly lower cell viability when compared with the blank group and the empty plasmid group (both P < 0.05); and the cell viability in the siRNA group decreased gradually with the increase of time. The results of flow cytometry and FITC-Annexin V/PI staining indicated that when compared with the blank group and the empty plasmid group, the proportion of cells in S phase was markedly lower and the apoptosis rate was significantly higher in the siRNA group (both P < 0.05). Our study suggests that inhibition of RACK1 could suppress cell proliferation and induce apoptosis in HCC MHCC97-H cells.

All-trans-retinoic acid activates SDF-1/CXCR4/ROCK2 signaling pathway to inhibit chondrogenesis.

Recent studies have indicated that ATRA inhibits chondrogenesis and can lead to congenital clubfoot (CCF). The molecular mechanism of ATRA-induced chondrogenesis is not clear. As RhoA/ROCK and SDF-1/CXCR4 signaling play important molecular roles for a variety of cellular processes, we hypothesized that RhoA/ROCK2 and SDF-1/CXCR4 signaling are involved in ATRA-induced chondrogenesis in rat embryo hind limb bud mesenchymal cells (rEHBMCs). We found that ATRA dose-dependently inhibits proliferation and expression of chondrogenic transcription factors (SOX9 and COL2A1) in rEHBMCs. In contrast, ATRA increases the expression of ROCK2, SDF-1 and CXCR4. Pharmacological inhibition of ROCK signaling and SDF-1/CXCR4 signaling by Y27632 and AMD3100, respectively, resulted in elevated expression of SOX9 and COL2A1. In addition, we found that disturbing SDF-1/CXCR4 signaling by AMD3100 decreases ATRA-induced ROCK2 expression. In vivo studies we also confirm that SOX9 expression of early-stage cartilage progenitors in the proliferative zone and COL2A1 expression in prehypertrophic chondrocytes are decreased in ATRA-treated rat embryo hind limb. Together, these results show that ATRA activates SDF-1/CXCR4/ROCK2 signaling to inhibit chondrogenesis to lead to CCF by suppressing differentiation through down-regulation of SOX9 and COL2A1 expression in rat embryo hind limb bud mesenchymal cells.

Serum selenium levels and prostate cancer risk: A MOOSE-compliant meta-analysis.

Some observational studies have shown that elevated serum selenium levels are associated with reduced prostate cancer risk; however, not all published studies support these results. A literature search of PubMed, Embase, Medline, and the Cochrane Library up until September 2016 identified 17 studies suitable for further investigation. A meta-analysis was conducted on these studies to investigate the association between serum selenium levels and subsequent prostate cancer risk. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the overall OR of prostate cancer for the highest versus the lowest levels of serum selenium. We found a pooled OR (95% CI) of 0.76 (0.64, 0.91; P < 0.05). In subgroup analysis, an inverse association between serum selenium levels and prostate cancer risk was found in each of case-control studies, current and former smokers, high-grade cancer cases, advanced cancer cases, and different populations. Such correlations were not found for subgroups containing each of cohort studies, nonsmokers, low-grade cancer cases, and early stage cancer cases. In conclusion, our study suggests an inverse relationship between serum selenium levels and prostate cancer risk. However, further cohort studies and randomized control trials based on non-Western populations are required.